Cancer Genetics Italia S.r.l. (Italia) was founded in 2009 and is a wholly owned subsidiary of Cancer Genetics Inc. (CGI), which is located in Rutherford, New Jersey (U.S.A.). CGI was founded by world-renowned human geneticist R.S.K. Chaganti, Ph.D., who is currently a senior faculty member at New York City’s Memorial Sloan-Kettering Cancer Center. CGI’s affiliation with major cancer centers, such as the Memorial Sloan-Kettering Cancer Center, the National Cancer Institute, and the Mayo Clinic, along with the firm’s foundation in world-class scientific Knowledge has enabled CGI to develop strong intellectual properties (IP) in solid and blood-borne cancers.

It is from this foundation that CGI Italia draws its ability to design and manufacture proprietary DNA-FISH Probes. Our DNA-FISH Probes detect a range of genetic aberrations such as translocations and copy number changes and are IP protected.

Our products are marketed globally, except within the United States, and are provided in a ready-to-use format as Research Use Only (RUO) or CE marked.


Our mission is to provide professionals with robustly designed DNA-FISH Probes that are highly specific, easy to interpret, and possess strong signal quality, for the clinical management of cancer patients.